Lv6
2200 积分 2022-11-16 加入
ADMA, cardiovascular disease and diabetes
22天前
已完结
Parabens as the double-edged sword: Understanding the benefits and potential health risks
2个月前
已完结
Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures
2个月前
已完结
Notch‐triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase
2个月前
已关闭
Mazdutide versus placebo in Chinese adults with type 2 diabetes
3个月前
已完结
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
3个月前
已完结
Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis
3个月前
已完结
Harnessing GLP‐1 Receptor Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon
3个月前
已完结
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
3个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
3个月前
已完结
皖公网安备34019202002308
